CTD Reports Initial Data for Two Clinical Trials of Trappsol® Cyclo™
CTD Holdings, Inc., a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical
Category: Uncategorized
Antibiotics degradation products against Alzheimer’s disease
A recent paper in Cell Reports published an interesting finding: polymeric degradation products (compound X and Z, respectively) of antibiotics
Effect of cosolvent on the complexation of caffeic acid
Caffeic acid is a phenolic compound found in several plants and fruits including coffee beans. It has high nutraceutical value
Fraud companies infiltrating cyclodextrin business
I would like to draw your attention to a very recent desperate approach for taking advantage of one’s naivety and